The Alpha-1 GABAA Receptor Regulates Alcohol-Drinking Behaviors

Alpha-1 GABAA 受体调节饮酒行为

基本信息

  • 批准号:
    7472115
  • 负责人:
  • 金额:
    $ 21.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): It is well established that the rewarding properties of ethanol [EtOH] are mediated in part by GABAA-receptor mechanisms; however, only recently has research demonstrated that the a1 receptor subunit, particularly those within the ventral pallidum [VP], may be the critical GABAergic receptor regulating EtOH reinforcement. The primary objective of this proposal will be to further evaluate the role of the GABAA a1-containing receptor subunit in regulating EtOH-seeking behaviors by employing a combination of neuropsychopharmacological and molecular biology techniques. To accomplish this goal, the selectively-bred high alcohol-drinking [HAD-1] rats will be used. The primary hypothesis to be tested is that a selective inhibition of the GABAA a1 receptor containing subunit within the VP of HAD-1 rats will lead to selective reductions in EtOH-motivated behavior, with little or no effect on sucrose-motivated behaviors. The inhibition of the GABAA a1 subunit will be accomplished by constructing a herpes simplex virus [HSV] vector, which will utilize the siRNA sequence specific, posttranscriptional gene silencing mechanism. This vector will then be infused directly into the VP of HAD-1 rats via bilateral guide cannulae. It is hypothesized that a selective reduction in EtOH-maintained responding will be observed following infusion of the vector-mediated siRNA amplicon into the VP. Specifically, reinforcer and neuroanatomical specificity will be expected, as neither suppression on sucrose maintained responding following infusion of the active virus in the VP, nor suppression on alcohol responding infusion of the active virus into the neuroanatomical control locus [e.g., caudate putamen] will be expected. In subsequent studies, a combination of in situ reverse transcriptase-PCR, immunohistochemistry, and Western analyses [immunoblotting] will be used to determine the success of the HSV-siRNA viral vector manipulations. These studies should extend our understanding of the role of the GABAA a1 receptor subtype in the regulation of alcohol-drinking behaviors.
描述(由申请人提供):已经确定乙醇[EtOH]的奖励特性部分由GABA A受体机制介导;然而,最近的研究表明,a1受体亚基,特别是腹侧苍白球[VP]内的亚基,可能是调节EtOH强化的关键GABA能受体。本提案的主要目的是通过采用神经精神药理学和分子生物学技术的组合,进一步评估GABAA α 1受体亚单位在调节EtOH寻求行为中的作用。为了实现这一目标,将使用选择性繁殖的高饮酒[HAD-1]大鼠。待检验的主要假设是,选择性抑制HAD-1大鼠VP内含有GABAA α 1受体的亚基将导致EtOH激发行为的选择性减少,对蔗糖激发行为影响很小或没有影响。GABAA α 1亚基的抑制将通过构建单纯疱疹病毒[HSV]载体来实现,该载体将利用siRNA序列特异性、转录后基因沉默机制。然后通过双侧引导插管将该载体直接输注到HAD-1大鼠的VP中。假设在将载体介导的siRNA扩增子输注到VP中后,将观察到EtOH维持的应答的选择性降低。具体而言,预期具有更好的和神经解剖学特异性,因为在VP中输注活性病毒后,既没有对蔗糖的抑制维持响应,也没有对酒精响应活性病毒输注到神经解剖学控制位点的抑制[例如,尾壳核]。在随后的研究中,将使用原位逆转录酶-PCR、免疫组织化学和Western分析[免疫印迹]的组合来确定HSV-siRNA病毒载体操作的成功。这些研究应该扩展我们对GABAA a1受体亚型在饮酒行为调节中的作用的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Harry L June其他文献

Harry L June的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Harry L June', 18)}}的其他基金

Anxiety and Alcoholism: Novel Benzodiazpine Treatments
焦虑和酗酒:新型苯二氮平治疗方法
  • 批准号:
    8399910
  • 财政年份:
    2009
  • 资助金额:
    $ 21.56万
  • 项目类别:
Anxiety and Alcoholism: Novel Benzodiazpine Treatments
焦虑和酗酒:新型苯二氮平治疗方法
  • 批准号:
    7739314
  • 财政年份:
    2009
  • 资助金额:
    $ 21.56万
  • 项目类别:
Anxiety and Alcoholism: Novel Benzodiazpine Treatments
焦虑和酗酒:新型苯二氮平治疗方法
  • 批准号:
    7938981
  • 财政年份:
    2009
  • 资助金额:
    $ 21.56万
  • 项目类别:
Efficacy of Novel Triple Uptake Inhibitors in Treating Alcoholism and Depression
新型三重摄取抑制剂治疗酒精中毒和抑郁症的功效
  • 批准号:
    8197938
  • 财政年份:
    2008
  • 资助金额:
    $ 21.56万
  • 项目类别:
Efficacy of Novel Triple Uptake Inhibitors in Treating Alcoholism and Depression
新型三重摄取抑制剂治疗酒精中毒和抑郁症的功效
  • 批准号:
    7584980
  • 财政年份:
    2008
  • 资助金额:
    $ 21.56万
  • 项目类别:
Efficacy of Novel Triple Uptake Inhibitors in Treating Alcoholism and Depression
新型三重摄取抑制剂治疗酒精中毒和抑郁症的功效
  • 批准号:
    8413222
  • 财政年份:
    2008
  • 资助金额:
    $ 21.56万
  • 项目类别:
The Alpha-1 GABAA Receptor Regulates Alcohol-Drinking Behaviors
Alpha-1 GABAA 受体调节饮酒行为
  • 批准号:
    7595244
  • 财政年份:
    2008
  • 资助金额:
    $ 21.56万
  • 项目类别:
Efficacy of Novel Triple Uptake Inhibitors in Treating Alcoholism and Depression
新型三重摄取抑制剂治疗酒精中毒和抑郁症的功效
  • 批准号:
    7746463
  • 财政年份:
    2008
  • 资助金额:
    $ 21.56万
  • 项目类别:
Efficacy of Novel Triple Uptake Inhibitors in Treating Alcoholism and Depression
新型三重摄取抑制剂治疗酒精中毒和抑郁症的功效
  • 批准号:
    8016023
  • 财政年份:
    2008
  • 资助金额:
    $ 21.56万
  • 项目类别:
GABAa Receptor Subunits in Alcohol Reinforcement
GABAa 受体亚基在酒精强化中的作用
  • 批准号:
    6745072
  • 财政年份:
    2002
  • 资助金额:
    $ 21.56万
  • 项目类别:

相似海外基金

Collaborative Research: Overlooked Oxidation of Aqueous Alcohols: Kinetics, Mechanism, and Relevance to Water Reuse
合作研究:被忽视的水醇氧化:动力学、机制以及与水回用的相关性
  • 批准号:
    2304861
  • 财政年份:
    2023
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Continuing Grant
STTR Phase I: Development of Modular Reactors to Convert Methane to Alcohols at Low Temperatures
STTR 第一阶段:开发在低温下将甲烷转化为醇的模块化反应器
  • 批准号:
    2151256
  • 财政年份:
    2023
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Standard Grant
Development of amine-dehydrogenase and lyase biocatalysts for the sustainable manufacturing of unnatural chiral amino acids and amino alcohols
开发胺脱氢酶和裂解酶生物催化剂,用于可持续生产非天然手性氨基酸和氨基醇
  • 批准号:
    2870226
  • 财政年份:
    2023
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Studentship
Collaborative Research: Overlooked Oxidation of Aqueous Alcohols: Kinetics, Mechanism, and Relevance to Water Reuse
合作研究:被忽视的水醇氧化:动力学、机制以及与水回用的相关性
  • 批准号:
    2304860
  • 财政年份:
    2023
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Continuing Grant
Postdoctoral Fellowship: MPS-Ascend: Development of Selective Reaction Schemes for Photoactivation of Alcohols
博士后奖学金:MPS-Ascend:醇光活化选择性反应方案的开发
  • 批准号:
    2316541
  • 财政年份:
    2023
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Fellowship Award
Development of phosphorylation of alcohols in protein based on the structural modification of phosphoenolpyruvate
基于磷酸烯醇丙酮酸结构修饰的蛋白质醇磷酸化研究进展
  • 批准号:
    22KJ1152
  • 财政年份:
    2023
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Nickel Cross-Coupling Cascades with α-Heteroatom Radicals to Prepare Sterically Hindered Alcohols and Amines
镍与α-杂原子自由基交叉偶联级联制备位阻醇和胺
  • 批准号:
    10604535
  • 财政年份:
    2023
  • 资助金额:
    $ 21.56万
  • 项目类别:
Towards a better understanding of the effect of the pentafluorosulfanyl group on the lipophilicity and acid/base properties of alcohols and amines
更好地了解五氟硫基对醇和胺的亲脂性和酸/碱性质的影响
  • 批准号:
    571856-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Alliance Grants
Pd-Catalyzed C(sp3)-H Functionalizations Directed by Free Alcohols and Boc-Protected Amines
由游离醇和 Boc 保护的胺引导的 Pd 催化 C(sp3)-H 官能化
  • 批准号:
    10606508
  • 财政年份:
    2022
  • 资助金额:
    $ 21.56万
  • 项目类别:
MPS-Ascend: Nickel/Photoredox-Catalyzed C(sp3)–C(sp3) Cross-Coupling Between Alkyl Halides and Activated Alcohols
MPS-Ascend:镍/光氧化还原催化的 C(sp3)→C(sp3) 烷基卤化物和活化醇之间的交叉偶联
  • 批准号:
    2213210
  • 财政年份:
    2022
  • 资助金额:
    $ 21.56万
  • 项目类别:
    Fellowship Award
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了